glp 1 cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist–based therapies: Trends in Endocrinology & Metabolism Cardiovascular effects of Glucagon-like peptide

Liraglutide shows dose-dependent nausea ratesVictoza (for diabetes) has rates around 10-17% depending on dose, while Saxenda (3.0 mg for weight management) has significantly higher nausea rates of approximately 39% according to its SmPC

PMID 2501587

MDD diagnostic status, overall depression severity and profiles The presence of DSM-IV diagnosis of MDD was assessed using the Composite Interview Diagnostic Instrument version 2.1 [35] administered by specially trained research staff

The risk also increased in relation to disease and therapy duration ( In conclusion, although pre-clinical data would support a role of insulin therapy as a risk factor for thyroid cancer, clinical data are still inconclusive